Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Stateside's Canadian Microcap Board -- Ignore unavailable to you. Want to Upgrade?

To: Dave@SI who wrote (1453)	1/18/2016 8:02:32 AM
From: ayeyou	Respond to of 1728

BCT has top notch medical personnel but they are definitely not stock promoters. Market in general sucks and with no news and no trial underway with pending results BCT price will continue to lag. I have been chipping away a few here and few there and getting a nice position together. I dont think we will see BCT anywhere near these lows once a clinical trial begins. They are trying to cure cancer here not remove a wart so of course this will be a drawn out affair. I am in for the long haul as I see this team as one of the best ever assembled for a trial and the fact that they have already shown some real success on human trials. No reason that success should not continue or improve. I like the odds.